J&J | JNJ - Trade Debtors


J&J reported $22.54B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Abbott USD 11.22B 655M Mar/2026
Amgen USD 10.23B 1.09B Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Baxter International USD 1.86B 158M Jun/2026
Bayer EUR 18.55B 4.36B Mar/2026
Becton, Dickinson and Co. USD 2.36B 159M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
Boston Scientific USD 3.03B 101M Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
CONMED USD 239.77M 11.11M Jun/2026
Cooper Companies USD 809.2M 2.1M Mar/2026
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 973M 60.9M Mar/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Globus Medical USD 739.28M 3.84M Jun/2026
Insulet USD 588.7M 44M Jun/2026
Integra LifeSciences USD 267.19M 2.78M Jun/2026
Intuitive Surgical USD 1.67B 77.6M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Merck USD 12.21B 435M Mar/2026
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Novartis USD 9.85B 252M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 492M 10M Jun/2026
Stryker USD 3.74B 172M Jun/2026
Tandem Diabetes Care USD 162.06M 21.39M Jun/2026
Teva Pharmaceutical Industries USD 3.49B 100M Jun/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026
Zimmer Biomet Holdings USD 1.77B 40.9M Jun/2026
Zoetis USD 1.57B 65M Jun/2026